Peroxisome Proliferator-Activated Receptor &ggr; Agonists as Insulin Sensitizers: From the Discovery to Recent Progress

E-ISSN： 1873-4294|8|17|1483-1507

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.8, Iss.17, 2008-11, pp. : 1483-1507

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in Peroxisome Proliferator-Activated Receptor Science

Current Medicinal Chemistry, Vol. 10, Iss. 4, 2003-01 ,pp. : 267-280

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Updates on Peroxisome Proliferator-Activated Receptor δ Agonists for the Treatment of Metabolic Syndrome

Medicinal Chemistry, Vol. 12, Iss. 1, 2016-02 ,pp. : 3-21

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor Agonists as Potential Therapeutic Agents in Multiple Sclerosis

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-11 ,pp. : 1129-1135

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR)&bgr; /&dgr;: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 46-55

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor-γ and its Agonists in Hypertension and Atherosclerosis: Mechanisms and Clinical Implications

By Halabi Carmen M. Sigmund Curt D.

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 6, 2005-01 ,pp. : 389-398

Adis International

Access to resources Recommend Favorite